GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 100 filers reported holding GOSSAMER BIO INC in Q2 2023. The put-call ratio across all filers is 3.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $41,900 | -38.0% | 34,917 | -34.9% | 0.00% | – |
| Q1 2023 | $67,609 | -94.4% | 53,658 | -46.3% | 0.00% | -100.0% |
| Q3 2022 | $1,198,000 | -85.1% | 100,000 | -89.6% | 0.01% | -85.3% |
| Q2 2022 | $8,064,000 | +203.8% | 963,400 | +705.0% | 0.03% | +142.9% |
| Q2 2019 | $2,654,000 | – | 119,673 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
| Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
| Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
| Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
| HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
| Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
| Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
| Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
| Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
| Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |